Data Collection for Patients With Low Grade Ovarian Carcinoma
Low-grade tumors of female organs are considered rare. Because of this, doctors do not know
the best treatment for these kinds of tumors. Researchers want to learn more about
patients' experience with these types of cancer to help find ways to develop better
therapies to treat them.
If you agree to take part in this study, information about your type of cancer, the type of
treatment you had or are having, and details about your follow-up care will be entered into
a research database. These data will be collected from patients seen at MD Anderson since
January, 1950. This information will serve as a basis for research studies about patients
with low-grade ovarian tumors.
Your data will mostly come from your MD Anderson medical record. However, information may
also be requested from you, your local doctor, or an outside hospital. Information collected
from sources other than MD Anderson will be included in your MD Anderson medical record as
well as entered into this study's database.
Information may be directly collected from you, if there are additional questions not
provided in your medical records, if your information is not complete, or if your
information collected from other sources does not match what is in your MD Anderson medical
To help ensure confidentiality, the database will be password-protected with access strictly
limited to study staff.
This research database will be updated at least once a year to include information about
your current treatment and/or follow-up care. This information is usually collected from
your MD Anderson medical record, or it may be necessary to contact you directly. This
information will be collected indefinitely. If you wish to end your participation in this
study, you may request that your data remain in the database or that your information be
deleted from the database.
This is an investigational study. Up to 1,000 patients will take part in this study. All
will be enrolled at MD Anderson.
Observational Model: Cohort
Data Collection for Patients with Low Grade Ovarian Carcinoma
David Gershenson, MD
M.D. Anderson Cancer Center
United States: Institutional Review Board
|UT MD Anderson Cancer Center||Houston, Texas 77030|